Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Seung-Jung Park, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01788592
First received: February 8, 2013
Last updated: December 8, 2014
Last verified: December 2014

February 8, 2013
December 8, 2014
January 2003
October 2013   (Final data collection date for primary outcome measure)
Major Adverse Cardiac Event [ Time Frame: 1year ]
Death from any causes, myocardial infarction or any repeat revascularization
Same as current
Complete list of historical versions of study NCT01788592 on ClinicalTrials.gov Archive Site
  • all cause Death [ Time Frame: 1year ]
  • Myocardial Infarction [ Time Frame: 1year ]
  • The composite of Death or myocardial infarction [ Time Frame: 1year ]
  • Any repeat revascularization [ Time Frame: 1year ]
  • Target vessel revascularization [ Time Frame: 1year ]
  • Target lesion revascularization [ Time Frame: 1year ]
  • New lesion revascularization [ Time Frame: 1year ]
  • Stent thrombosis by Academic Research Consortium criteria [ Time Frame: 1year ]
Same as current
Not Provided
Not Provided
 
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice
The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.
Not Provided
Observational [Patient Registry]
Observational Model: Cohort
Time Perspective: Prospective
1 Year
Not Provided
Non-Probability Sample
consecutive patients amenable to percutaneous coronary intervention with drug eluting stents
Coronary Artery Disease
Not Provided
Drug eluting stent
Patients who receiving drug eluting stents
Park SJ, Ahn JM, Park GM, Cho YR, Lee JY, Kim WJ, Han S, Kang SJ, Park DW, Lee SW, Kim YH, Lee CW, Mintz GS, Park SW. Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice. Eur Heart J. 2013 Nov;34(43):3353-61. doi: 10.1093/eurheartj/eht404. Epub 2013 Oct 2.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
5097
October 2013
October 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • coronary disease amenable to percutaneous coronary intervention (PCI)
  • no clinical and lesion limitations

Exclusion Criteria:

  • patients with a mixture of several drug eluting stents
  • terminal illness with life expectancy less than 1 year
  • patients with cardiogenic shock
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01788592
AMCCV2013-02
No
Not Provided
Not Provided
Not Provided
Seung-Jung Park, Asan Medical Center
Seung-Jung Park
Not Provided
Principal Investigator: Seung-Jung Park, MD, PhD Asan Medical Center
Asan Medical Center
December 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP